| PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT05340270) | Guangxi Medical University | 2022-07-15 |
| Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy (NCT05383716) | Peking Union Medical College Hospital | 2022-07-01 |
| Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. (NCT06376773) | Fujian Medical University | 2022-06-01 |
| Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery (NCT05455632) | Shanghai Jiao Tong University School of Medicine | 2022-06-01 |
| Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer (NCT05371197) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-05-05 |
| A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer (NCT05376722) | Hongqian Guo | 2022-02-22 |
| Development and Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer (NCT06909643) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-01-01 |
| A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC (NCT05172440) | Hongqian Guo | 2021-12-09 |
| Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy (NCT04848454) | Peking University First Hospital | 2021-11-20 |
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer (NCT05161572) | Fudan University | 2021-09-28 |
| Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma (NCT05024266) | First Affiliated Hospital of Zhejiang University | 2021-08-01 |
| Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial (NCT05165225) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-07-13 |
| Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy (NCT04932460) | First Affiliated Hospital, Sun Yat-Sen University | 2021-06-15 |
| The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients (NCT04986306) | National Cheng-Kung University Hospital | 2021-05-20 |
| Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy (NCT06212440) | National Cancer Center, Korea | 2021-05-04 |
| Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial (NCT05223582) | Fudan University | 2021-05-01 |
| Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer (NCT04799639) | Sun Yat-sen University | 2021-03-18 |
| Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer (NCT04776590) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-01-28 |
| Neoadjuvant Therapy for Locally Advanced Colon Cancer (NCT04625803) | Zhejiang University | 2021-01-04 |
| Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients (NCT04696939) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-01-01 |
| Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer (NCT04743102) | Beijing Chao Yang Hospital | 2021-01-01 |
| Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC (NCT04947241) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2020-12-15 |
| Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma (NCT04666090) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-11-23 |
| Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma (NCT04588987) | Sun Yat-sen University | 2020-10-01 |
| Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients (NCT04440982) | Lumicell, Inc. | 2020-09-01 |
| Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer (NCT04486495) | Maastricht University Medical Center | 2020-07-16 |
| A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis (NCT04440605) | Peking University | 2020-07-01 |
| Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Squamous Cell Carcinoma (pLINE) (NCT04440332) | Sichuan Cancer Hospital and Research Institute | 2020-07-01 |
| Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (NCT04385654) | West China Hospital | 2020-06-01 |
| Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy (NCT05512468) | Fujian Medical University Union Hospital | 2020-03-01 |
| Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS) (NCT04717947) | Hospital Clinic of Barcelona | 2020-02-25 |
| Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer (NCT05406999) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2020-02-01 |
| Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer (NCT04227886) | Fudan University | 2019-12-01 |
| A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer (NCT04062058) | Jing Jin, M.D. | 2019-11-20 |
| Study of CT and MR in the Gastric Cancer (NCT04028375) | Henan Cancer Hospital | 2019-09-01 |
| Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer (NCT03926338) | Sun Yat-sen University | 2019-05-10 |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer (NCT05906407) | German Cancer Research Center | 2019-04-19 |
| Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy (NCT03080116) | Universitaire Ziekenhuizen KU Leuven | 2019-03-28 |
| Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer (NCT03564171) | Sunnybrook Health Sciences Centre | 2018-07-18 |
| Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy (NCT07329920) | Guo ShiWei | 2018-07-10 |
| Divestment for Artery-involved Pancreatic Cancer (NCT03443921) | The First Affiliated Hospital with Nanjing Medical University | 2018-03-01 |
| Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer (NCT03192735) | Chang-Ming Huang, Prof. | 2017-09-01 |
| Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer (NCT03615170) | Zhejiang Cancer Hospital | 2017-07-19 |
| Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas (NCT03178032) | Clinica Universidad de Navarra, Universidad de Navarra | 2017-05-26 |
| Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China (NCT03437837) | Peking University First Hospital | 2017-05-01 |
| RISAS Procedure in Node Positive Breast Cancer Following NAC (NCT02800317) | Erasmus Medical Center | 2017-03-30 |
| Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes (NCT07147374) | Peking Union Medical College Hospital | 2017-02-01 |
| Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer (NCT03040180) | Zealand University Hospital | 2017-01-01 |
| Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer (NCT02769104) | Zhejiang Cancer Hospital | 2016-05-01 |
| A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma (NCT02301481) | Chinese Academy of Medical Sciences | 2014-01-01 |
| Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer (NCT01849380) | Shandong University | 2013-06-01 |
| A Study to Correlate Ultrasound Elastography With Histopathology to Monitor the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy (NCT01737970) | Oxford University Hospitals NHS Trust | 2012-02-01 |
| The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer (NCT01023802) | Mayo Clinic | 2009-02-01 |
| Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade (NCT06630481) | Seoul National University Hospital | 2009-01-01 |
| Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer (NCT06385912) | Tongji Hospital | 2006-07-01 |
| Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer (NCT00506623) | National Cancer Center, Korea | 2004-07-01 |